Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 20;13(6):e0197876.
doi: 10.1371/journal.pone.0197876. eCollection 2018.

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project

Almudena Pérez-Rodríguez  1 , Javier Batlle  1 , Irene Corrales  2   3 , Nina Borràs  2   3 , Ángela Rodríguez-Trillo  1 , Esther Lourés  1 , Ana Rosa Cid  4 , Santiago Bonanad  4 , Noelia Cabrera  4 , Andrés Moret  4 , Rafael Parra  3   5 , María Eva Mingot-Castellano  6 , Nira Navarro  7 , Carmen Altisent  5 , Rocío Pérez-Montes  8 , Shally Marcellini  9 , Ana Moreto  10 , Sonia Herrero  11 , Inmaculada Soto  12 , Nuria Fernández Mosteirín  13 , Víctor Jiménez-Yuste  14 , Nieves Alonso  15 , Aurora de Andrés Jacob  16 , Emilia Fontanes  17 , Rosa Campos  18 , María José Paloma  19 , Nuria Bermejo  20 , Rubén Berrueco  21 , José Mateo  22 , Karmele Arribalzaga  23 , Pascual Marco  24 , Ángeles Palomo  6 , Nerea Castro Quismondo  25 , Belén Iñigo  26 , María Del Mar Nieto  27 , Rosa Vidal  28 , María Paz Martínez  29 , Reyes Aguinaco  30 , Maria Tenorio  31 , María Ferreiro  32 , Javier García-Frade  33 , Ana María Rodríguez-Huerta  34 , Jorge Cuesta  35 , Ramón Rodríguez-González  36 , Faustino García-Candel  37 , Manuela Dobón  38 , Carlos Aguilar  39 , Fernando Batlle  40 , Francisco Vidal  2   3   41 , María Fernanda López-Fernández  1
Affiliations

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project

Almudena Pérez-Rodríguez et al. PLoS One. .

Abstract

The multimeric analysis (MA) of plasma von Willebrand factor (VWF) evaluates structural integrity and helps in the diagnosis of von Willebrand disease (VWD). This assay is a matter of controversy, being considered by some investigators cumbersome and only slightly informative. The centralised study 'Molecular and Clinical Profile of von Willebrand Disease in Spain (PCM-EVW-ES)' has been carried out by including the phenotypic assessment and the genetic analysis by next generation sequencing (NGS) of the VWF gene (VWF). The aim of the present study was to evaluate the role of MA to the diagnosis of these patients and their potential discrepancies. Two hundred and seventy out of 480 patients centrally diagnosed with VWD had normal multimers, 168 had abnormal multimers and 42 a total absence of multimers. VWF MA was of great significance in the diagnosis of 83 patients (17.3%), it was also of help in the diagnosis achieved in 365 additional patients (76%) and was not informative in 32 cases (6.7%). With regard to discrepancies, 110 out of 480 (23%) patients centrally diagnosed with VWD presented some kind of discordance between VWF:RCo/VWF:Ag and/or VWF:CB/VWF:Ag ratios, multimeric study and/or genetic results. The VWF MA was key in the presence of novel mutations as well as in cases with phenotypic discrepancies. A comparison between the contribution of MA and VWF:CB showed a clearly higher contribution of the former in the diagnostic process. These data seem to reinforce the relevance of the VWF MA in VWD diagnosis, despite all its limitations.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist. The funders provided support but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, as well as they do not alter our adherence to PLOS ONE policies on sharing data and materials. The only implication in the study of the funding organizations was to provide financial support for the development of the project (sample collection and shipment and for research materials). The Project “Molecular and Clinical Profile of VWD in Spain (PCM-EVW-ES) SPANISH REGISTRY” has been registered at www.clinicaltrials.gov Protocol Registration and Results System. (Study: Identifier: NCT02869074RE. Responsible Party Francisco Javier Batlle Fonrodona). Affiliation: Spanish Society on Thrombosis and Haemostasis (SETH). Last Public Release: 10/03/2017. The Banc de Sang i Teixits (Blood and Tissue Bank) is a public agency of the Catalan Department of Health. For more information you can visit the web page: https://www.bancsang.net/info-corporativa/en_missio/.

Figures

Fig 1
Fig 1. Evaluation of the contribution of different laboratory steps in the diagnosis definition.
Four different successive laboratory assessment steps are considered. The progress in the diagnostic definition of the patients according to each step is shown. After the first and second steps, the multimeric analysis (MA) was of great significance in the diagnosis definition of 83 additional patients. Moreover, MA was in agreement with the diagnostic definition accomplished in steps 1 and 2 (179 patients). Finally, MA was also in agreement with the diagnostic definition achieved by molecular analysis in 186 additional patients. Thus, MA contributed to the diagnosis definition in a total of 448 (93.3%) patients.
Fig 2
Fig 2
Comparison between the diagnostic definition contribution of VWF:CB (in step “screening tests” [a]) and the multimeric analysis (MA) instead of VWF:CB first step, (step “screening tests” [b]). A greater degree of efficiency was observed for MA (50.4% versus 33.1% for VWF:CB).
Fig 3
Fig 3. Distribution of patients according to their coincidence between ratios and multimeric analysis before genetic study and between multimeric analysis and mutation after genetic study.
Of 110 patients with some type of discrepancy, in 76 (48 + 28) the MA was in line with the molecular study while in 18 (14+4) patients there was not concordance. In the remaining 16, the similarity could not be demonstrated because the mutation found has not been described previously.
Fig 4
Fig 4. Multimeric analysis of von Willebrand factor (VWF) in low-resolution SDS-agarose gels in patients with type 2A VWD and some discrepancy.
VWF from platelet lysate (NPt), plasmas of a normal subject (NP), patients with type 2A VWD and a patient with VWD type 2A (IIA) used as a control 2A are shown. (a-b): Patients with discrepancy between ratios and multimeric analysis; (c-d): Patients re-classified as type 2A on the basis of the genetic study.
Fig 5
Fig 5. Multimeric analysis of von Willebrand factor (VWF) in low-resolution SDS-agarose gels in patients with type 2A/2M VWD and some discrepancy.
VWF from platelet lysate (NPt), plasmas of a normal subject (NP), patients with type 2A/2M VWD and a patient with VWD type 2A (IIA) used as a control 2A are shown. (a-c) Patients that showed discrepancy between ratios and multimeric analysis. In the case of the patients C30P012F07, C30P013F08 and C37P003F03 the mutations had not been described previously and the multimeric analysis (smeary) was of great significance to establish the diagnosis.
See this image and copyright information in PMC

References

    1. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003; 1(7): 1335–1342. - PubMed
    1. Leebeek FW, Eikenboom JC. Von Willebrand’s Disease. N Engl J Med 2016; 375(21): 2067–2080. Review. doi: 10.1056/NEJMra1601561 - DOI - PubMed
    1. Batlle J, Pérez-Rodríguez A, Pinto JC, Loures E, Rodríguez-Trillo A, López-Fernández MF. Diagnosis and management of von Willebrand disease in Spain. Semin Thromb Hemost 2011; 37(5): 503–510. doi: 10.1055/s-0031-1281036 - DOI - PubMed
    1. Costa-Pinto J, Pérez-Rodríguez A, del C Gomez-del-Castillo M, Lourés E, Rodríguez-Trillo A, Batlle J et al. Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies. Haemophilia 2014; 20(4): 559–567. - PubMed
    1. Veyradier A, Boisseau P, Fressinaud E, Caron C, Ternisien C, Giraud M et al. A laboratory phenotype/genotype correlation of 1167 French patients from 670 families with von Willebrand disease: a new epidemiologic picture. Medicine (Baltimore) 2016; 95(11): e3038. - PMC - PubMed

Publication types

Substances